Chronic pelvic pain syndrome (CPPS) is a common and serious health problem affecting the quality of life in men. In this study, we aim to investigate the manganase superoxide dismutase (MnSOD) polymorphism at nucleotide 47 as a result of the change of Ala to Val on the protein sequence in CPPS patients. The frequencies were 0.45 and 0.38 for the Ala and 0.55 and 0.62 for Val in National Institutes of Health category 3a and 3b groups. The differences between control and CPPS patients were statistically significant (Po0.05). However, frequencies recorded in 3a and 3b groups were not statistically different (P40.05). Same results were obtained for enzyme analysis of MnSOD and glutathione peroxidase. Control group antioxidant enzyme levels were higher than patients' samples. The low antioxidant status of CPPS patients might be the clue for pathophysiological problems, and highly distributed Val allele frequency can be a mediator point of the illness. Our findings lead to the suggestion that oxidative disorder-linked medical health problems can be associated with genetic risk factors such as polymorphisms.
Introduction
Chronic prostatitis is a major health-care issue, and management of chronic prostatitis symptoms is still poor. 1 Considerable confusion exists about the clinical findings associated with prostatitis and the effect of these conditions on male reproductive physiology. Chronic prostatitis is defined by lower urinary tract symptoms, predominantly with pain. The diagnosis is made when neurologic, infectious and urologic diseases (e.g. benign prostatic hyperplasia or kidney stones) are excluded. Symptoms in patients with chronic prostatitis may last several weeks or more and may recur periodically for many years. The National Institutes of Health (NIH) classification and definition of the four categories of prostatitis defines category IIIa as an inflammatory chronic pelvic pain syndrome (CPPS) with white blood cells (WBCs) in semen, expressed prostatic secretions (EPSs) or voided bladder 3 (VB3). Category IIIb is defined as a noninflammatory CPPS without WBCs in semen, EPSs or VB3. 2, 3 However, the presence of inflammatory cells in EPSs correlates poorly with the presence of inflammatory cells in semen. Predominantly, neurophils were found as a response to generation of reactive oxygen species (ROS) in semen. Increased levels of free radicals may also cause defected spermatozoa and impaired sperm function in infertile men. 4 There is still controversy concerning the gold standard treatment for this chronic disease; thus, a proper diagnostic technique for inflammatory and noninflammatory CPPS still remains to be defined. 5 Therefore, CPPS may be caused by auto-immune response disorders or another factor. In recent studies, ROS levels of prostatitis patients' semen samples did not verify the illness. Increase in ROS levels and subsequent activation of scavenging enzymes might prevent DNA damages by inducing DNA repair mechanisms. One of the most important key antioxidant enzymes is manganese superoxide dismutase (MnSOD), which is a homotetrameric enzyme that protects mitochondria against ROS by scavenging superoxide anions produced from the electron transport system. 6 A common polymorphism exists in the human MnSOD gene. This Ala-9-Val polymorphism is a single-nucleotide substitution of C-T at nucleotide 47, changing the encoded amino acid from Ala (GCT) to Val (GTT). 7 The amino-acid change occurs within the N-terminal mitochondrial targeting sequence, a 24-amino-acid signal sequence that targets the MnSOD precursor protein for transport into the mitochondria. Mitochondrial localization of MnSOD is required to protect cells from ionizing radiation and other forms of oxidative damage. 8 The variant residue is in the nine amino acids upstream of the cleavage site, hence polymorphism designation Ala-9Val. The different geno-type of MnSOD has previously been associated with various diseases including Diabetus mellitus, tardive dyskinesia and pancreatic, bladder, lung, breast and testis cancer. [9] [10] [11] [12] [13] Previous data established that the total antioxidant status of prostatitis patients is not in the normal range. Accelerated radical oxygen species amount causes the overexpression of antioxidant enzymes. Although many studies have been carried out, the exact mechanism of antioxidant status of prostatitis is still under debate. 1 In this study, we aim to determine MnSOD polymorphism and different genotypes of MnSOD associated with its antioxidant enzyme activity in CPPS patients.
Materials and methods

Patients, definitions and selection criteria
Out of a study group comprising 71 patients who met the diagnostic criteria for chronic prostatitis, 40 patients met the criteria for NIH category 3a and 31 patients met the NIH criteria for category 3b, classified clinically on the basis of four-glass test results (Table 1 ). Apart from these 71 patients, a further 12 patients were excluded from the study owing to their incompatibility with the set criteria (Supplementary data 1). The following criteria were approved for research studies on chronic nonbacterial rostatitis/CPPS. 2 The Helsinki Declaration was strictly observed regarding the use of human samples. Also, all studies were undertaken with the approval and institutional oversight of the Institutional Review Board for Ethics of Human Subjects. All 71 patients were later compared on the basis of Endtz test results. Thirty-six healthy donors with normal semen characteristics as proven by various reports were recruited as controls. Donors with a history of genitourinary infection, symptoms or instrumentation were excluded from the study. Forty-six of 71 patients were (65%) smokers and seven of 71 (10%) gave up smoking in the last 5 years and the rest never smoked. The case and control groups were not using antioxidant pills regularly while consuming vegetables and meat products on a regular basis.
Semen analysis
Semen samples were collected by masturbation into sterile containers after at least 72 h of sexual abstinence. After liquefaction, semen specimens were evaluated for semen volume, appearance and viscosity. Semen characteristics (concentration, motility and morphology)
were examined in accordance with WHO criteria. 14 Computer-assisted semen analyzer were loaded for 5 ml for each semen sample and motile cells were examined (Table 1) .
WBCs
The presence of WBCs in semen specimens was assessed by the myeloperoxidase (Endtz) test. 15 A 20 ml volume of liquefied semen was placed in a 1.5 ml cryogenic vial, followed by 20 ml of phosphate-buffered saline (pH 7.0) and 40 ml of benzidine solution. The sample was mixed, allowed to sit for 5 min and examined for cells that had stained brown, indicating cells positive for peroxidase. Leukocytospermia was defined as 1 Â 10 6 or more WBC/ ml of semen ( Table 2) .
DNA isolation and polymerase chain reaction DNA was extracted from whole blood using the Qiagen Blood DNA extraction kit (Qiagen, GmbH, Hilden, Germany) from each specimen. The C1183T singlenucleotide polymorphism that defines the amino-acid change of alanine to valine-9 in the mitochondrial signalling sequence of MnSOD introduces a BsaW1 restriction (New England BioLabs, Hertfordshire, UK) site as described previously.
9 A 20-50 ng portion of genomic DNA was amplified using 50 pmol primers (nt 1110-1130: 5 0 -TAGACGGTCCCGCGGCGCTGA-3 0 and nt 1243-1219: 5 0 -CCGTAGTCGTAGGGCAGGTCGGGGA-3 0 ) in Master Mix polymerase chain reaction (PCR) Kit (Qiagen, Germany) containing 25 mM of each primer, 2 mM of each dNTP and 2.5 U Taq DNA polymerase. Amplification was carried out for 35 cycles by denaturating at 941C for 1 min, annealing at 581C for 2 min, extension at 721C for 2 min and final extension at 721C for 10 min for one cycle. PCR products of 260 bp were MnSOD polymorphism in prostatitis ED Arisan et al digested with BsaW 1 at 601C for 16 h. All digested products were analyzed with a 1000 bp DNA ladder in 3.0% agarose gel with ethidium bromide (Figure 1 ).
Antioxidant enzyme activity in blood and semen specimens
Blood samples were centrifuged for 2 min at 1500 r.p.m. at room temperature and plasma was separated into a clean tube. After liquefaction, semen samples were centrifuged at 1500 r.p.m. for 5 min at 41C. Seminal plasma was separated into aliquots and frozen at À201C for later measurement of all enzyme activity. Two hundred microliters of blood plasma or semen samples was analyzed for each enzyme activity spectrophotometrically (Shimadzu, Kyoto, Japan). Glutathione peroxidase (Gsh-Px) and superoxide dismutase (SOD) enzyme activities were determined according to the manufacturer's instructions using RANSEL for Gsx-Px and RANSOD SOD enzymes detection kit (RANDOX, Hertfordshire, UK).
Statistical analysis
The laboratory researchers were unaware about casecontrol status. Differences in MnSOD allele frequencies between cases and controls were determined using a w 2 test. Departures from Hardy-Weinberg equilibrium were determined by comparing the observed genotype frequencies with expected genotype frequencies calculated using observed allele frequencies. The effects of genetic polymorphism on the risk of CPPS were estimated using odds ratio and its 95% confidence interval, which were derived from unconditional multivariate logistic regression analysis. Deviations from Hardy-Weinberg frequencies in cases and controls were compared using the twosided P-value determination test by SPSS version 11.0. The enzyme activity results were expressed as mean7 standard error. All experiments were replicated in triplicate. Student's t-test was used for comparison between NIH-classified CPPS patients and control subjects. The 0.05 level was selected as the point of minimal statistical significance.
Results
MnSOD genotypes and allele frequencies among CPPS patients and disease-free control group were evaluated. Table 3 ). This followed the pattern of 16 of 36 (44%) Ala/Ala, 16 of 36 (44%) Ala/Val and four of 36 (12%) Val/Val. Although differences between type 3a and 3b were nonsignificant, difference rates were meaningful between CPPS and disease-free control group (P ¼ 0.046 and 0.084, w 2 ¼ test, Table 3 ). Three of 40 in category 3a and four of 31 in category 3b patients had comorbidities such as cardiovascular problems. However, the determination of the allele frequency in each group was not meaningful in overall group statistics (P ¼ 0.065 and 0.053).
We also investigated the specific SOD and related GshPx enzyme activity in serum and sperm samples. Antioxidant defense levels in serum and semen homogenates of control, type 3a and 3b CPPS patients are summarized in Figure 2a and b. As can be observed, total SOD and Gsh-Px activity were pointing in the same direction and the most remarkable results were obtained from the blood analysis. Control patients always had the highest enzyme activity. SOD enzyme activity was MnSOD polymorphism in prostatitis ED Arisan et al 1.8-and 1.2-fold higher in control groups compared to enzyme levels recorded for type 3a and type 3b patients for semen analyses. This ratio was the same in blood samples as 2.2-and 1.8-fold increments seen among the control specimens. In comparison to SOD enzyme activity, Gsh-Px enzyme activity demonstrated a more striking difference between the groups for all sample types. Control patients had 3.5-and 2.23-fold higher GshPx activity than type 3a and type 3b patients in semen analysis. In blood samples of these patients, four and three times lower Gsh-Px enzyme activity was detected, respectively. When all the results were calculated for SOD and Gsh-Px enzyme analysis, a significant (Po0.05) reduction of levels for each case was obtained.
Discussion
Antioxidant enzymes such as SOD, peroxidases and catalase act as sensitive regulators to protect cells from damage by oxygen-free radicals. 1, 10, 11 Recent studies on colorectal, lung, breast, bladder and gastrointestinal cancers, asthma, Diabetus mellitus, schizophrenia and Parkinson's disease revealed a decreased antioxidant activity in these patient samples compared to diseasefree controls. 14, 16, 17 The substitution of T to C in the mitochondrial targeting sequence of MnSOD gene leads to an amino-acid exchange in signal peptide, resulting in a conformational change of the protein. 18 This conformational change in protein structure has a direct effect on the manganese-containing SOD leading to a decrease in the defense capacity of mitochondria. Ala/Val variation in the MnSOD leader signal affects the activity of the enzyme. 6, 8 The conformations of the Ala-and Val-type leader signals have been predicted: the Ala form has an alpha helical structure, a common conformation for mitochondrial leader signals, whereas the Val form might change the conformation from alpha helix to a beta sheet starting from position 16 owing to amino-acid substitution. 10, 11 The Val form is less efficiently transported from mitochondria than the Ala form of the enzyme. Poor signal sequence recognition by a receptor in the inner mitochondrial membrane results in the mistargetting. In addition, inefficient cleavage of a particular signal may reduce the level of enzyme activity of an imported protein, such as MnSOD. There are many studies that have investigated MnSOD polymorphism related to various diseases. 12, 17, 19 However, it is still unclear how conformational change in the protein affects patients with several inflammatory diseases representing enhanced superoxide production and decreased superoxide scavenging activity. Current diagnostic methods and treatment modalities for CPPS are inadequate and new strategies need to be developed. In few studies evaluating the role of cytokines in CPPS, some of the proinflammatory cytokines were used to document the presence of inflammation. 20, 21 Men with CPPS had elevated levels of tumor necrosis factor-a and interleukin-1b, indicating the presence of inflammation as a feature of the disease, irrespective of the presence or absence of leukocytes in the EPSs. Despite these data, NIH classification is not enough to determine the pathophysiological responses during CPPS.
In this study, we have presented data showing the role of genetic factors directly related to oxidative stress in CPPS. Shimoda-Matsubayashi et al. 8 suggested that the Ala allele was associated with higher activity, and that higher activity can induce antioxidant enzyme protection, inducing production of H 2 O 2 . 4, 5 In our study, we found an increased frequency of Ala allele in the control group with high levels of antioxidant enzyme activity. Additionally, we have also checked the Gsh-Px activity levels and demonstrated a significant increase in the enzyme activity in disease-free conditions. It is well known that Gsh-Px enzyme activity is related to MnSOD enzyme production. The substrate of Gsh-Px is H 2 O 2 , mainly produced as an end product of MnSOD activity. Our results supported the protective ability of high antioxidant enzyme levels in the patient profile. These results do not provide for a satisfactory reason for classification between type 3a and 3b because among these groups, the differences in enzyme activity are not significant (P40.05). Nevertheless, control samples were remarkably different in their enzyme activity from the patient groups (Po0.05). Ala-and Ala/Val-type characters were widely distributed in our study. The homozygote Val character can be associated with illness types. In this study, 88% of control patients had Ala and Ala/Val character and 12% had Val homozygote character. The type 3a and type 3b CPPS patients, however, have 37 and 58% Val homozygote character. This allele frequency distribution between groups may be an important clue to understand the general antioxidant system failure. We also investigated the other pathophysiological problems that can lead to antioxidant defense system failure, as established by the enzyme levels. However, MnSOD polymorphism and other illnesses were not significantly related (P40.05). When we investigated our patients one by one for their MnSOD genetic allele distribution and enzyme activity levels, there was a strong relationship between low antioxidant enzyme activity and Ala or Val allele disturbance. On the other hand, our results are compatible with previous reports, which prove that patients with Tardive dyskinasea (TD) had a lower SOD activity than those without TD. 6 However, these reports have not shown the relationship between specific MnSOD activity and the occurrence of TD, and not all studies clearly identified the relationship between polymorphism and enzyme activity.
It is well known that the high frequency of distributed Val allele is a problem in breast cancer, Parkinson's disease, prostate cancer, Diabetus mellitus and schizophrenia. 6, 9, 13, 16, 17, 21 Based on the results of the previous studies, it is believed that the reason why Ala allele was more likely to be associated with a low risk for disease development than the Val allele was that the former may induce higher MnSOD activity, thereby leading to an increased capacity for defense against antioxidants. [19] [20] [21] [22] [23] In conclusion, we assessed the relationship between CPPS and free radicals, focusing on MnSOD, which is involved in the antioxidant defense system. We assumed that antioxidant injury caused by the impaired antioxidant enzyme MnSOD might contribute to adverse developments in the pathogenic cascade of CPSS patients. The low antioxidant status of patients is a clue for pathophysiological problems and highly distributed Val allele frequency can be a mediator point of the illness. Our findings lead to the suggestion that oxidative disorder-linked medical health problems can be associated with genetic risk factors such as polymorphism.
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